Blog | HemaCare

Skin Cells to Stem Cells: The New Face of Cellular Therapy

Nov 5, 2014 1:00:33 PM / by James Sanchez posted in Innovation, iPSCs, research, Sox2, Stem Cells, white blood cells

0 Comments

Scientists have discovered a way to convert human skin cells into transplantable white blood cells via stem cells.

All posts

Posts by Topic

research (264)
Stem Cells (123)
Innovation (83)
Dendritic Cells (62)
T Cells (53)
Cancer Immunology (46)
Cell Therapy (46)
Cytotoxic T Cells (40)
cancer immunotherapy (39)
Stem Cell Therapy (38)
peripheral blood mononuclear cells (36)
Bone Marrow (32)
Cancer (31)
Immunotherapy (31)
Regenerative Medicine (27)
Independent validation (24)
PBMCs (24)
Uncategorized (24)
stem cell therapy (24)
Peripheral blood cells (21)
CD34 (19)
induced pluripotent stem cells (19)
stem cell research (19)
stem cell transplantation (18)
Peripheral Blood Mononuclear Cell (17)
bioresearch (17)
clinical trial (17)
iPSCs (16)
PBMC (15)
cellular reprogramming (14)
hematopoietic stem cells (14)
immune system (13)
leukemia (13)
white blood cells (13)
CAR-T (12)
drug development (12)
T lymphocytes (11)
cd 34 stem cells (11)
mesenchymal stem cells (11)
HIV (10)
bone marrow (10)
dendritic cell vaccine (10)
Assay Development (9)
Drug Discovery (9)
Gene Therapy (9)
cancer treatment (9)
clinical trials (9)
drug screening (9)
PBCs (8)
apoptosis (8)
disease-state cells (8)
tissue engineering (8)
Cord Blood (7)
Mononuclear Cells (7)
aging (7)
chemotherapy (7)
B Cells (6)
Multiple Sclerosis (6)
Whole Blood (6)
autoimmune disease (6)
leukopaks (6)
Apheresis (5)
CD4+ T cells (5)
FDA (5)
GVHD (5)
HSCs (5)
Helper T Cells (5)
Hematopoietic History (5)
Inflammation (5)
Macrophages (5)
Tumors (5)
bone marrow stem cells (5)
bone marrow-derived stem cells (5)
breast cancer (5)
diabetes (5)
heart disease (5)
sickle cell disease (5)
tumor cells (5)
CD8+ T cells (4)
NK Cells (4)
TLR9 (4)
antibodies (4)
bioreasearch (4)
cancer vaccine (4)
cell quality (4)
embryonic stem cells (4)
gene editing (4)
lupus (4)
microbiome (4)
natural products (4)
new immunotherapy advances (4)
pancreatic cancer (4)
type 1 diabetes (4)
vaccine (4)
vaccines (4)
3D tissue culture (3)
Alzheimer's disease (3)
CD133+ (3)
CD4 (3)
CLL (3)
CXCR4 (3)
Cell Therapy Manufacturing (3)
Cryopreservation (3)
Dendritic Cell Immunotherapy (3)
GMP (3)
Leukopak (3)
Nanotechnology (3)
Neutrophils (3)
Platelets (3)
autoimmune diseases (3)
biomedical research (3)
brain cancer (3)
cGMP (3)
chronic lymphocytic leukemia (3)
customizable cytotoxic T cells (3)
heart attacks (3)
hematopoietic stem cell transplantation (3)
immune cells (3)
infection (3)
lymphocytes (3)
lymphoma (3)
neural stem cells (3)
neutrophil (3)
quality control (3)
tumor (3)
zinc finger nucleases (3)
AIDS (2)
ALL (2)
ALS (2)
Angina (2)
Autoimmune Disorders (2)
Bone (2)
CBER (2)
CCR5 (2)
CD19 (2)
CNS/Neurodegeneration (2)
CRISPR (2)
CRS-207 (2)
CTL019 (2)
CTLA-4 (2)
Cardiovascular Disease (2)
Ebola (2)
GMP Cellular Therapeutics (2)
GVAX (2)
HIV latency (2)
HPV (2)
Lung (2)
Lyme Disease (2)
Monocytes (2)
Natural Killer Cells (2)
PD-1 (2)
PD-L1 (2)
PDAC (2)
Parkinson's disease (2)
SLE (2)
SNP (2)
T-cell receptors (2)
Treg Cells (2)
Tregs (2)
acute lymphoblastic leukemia (2)
adipose-derived stem cells (2)
adoptive cell therapy (2)
antibody therapeutics (2)
antigens (2)
arthritis (2)
autism (2)
autologous stem cell therapy (2)
bacteria (2)
bioresearch products (2)
bone marrow transplantation (2)
cancer prevention (2)
cardiac stem cells (2)
cell therapy starting material (2)
cells (2)
clinical grade compliance (2)
colorectal cancer (2)
convalescent plasma therapy (2)
crohn's disease (2)
cytokine release syndrome (2)
cytomegalovirus (2)
disease (2)
disease cells (2)
disease state primary cells (2)
disease-state products (2)
engraftment (2)
food allergy (2)
genes (2)
genetic defects (2)
glioblastoma (2)
graft versus host disease (2)
heart failure (2)
hepatitis (2)
human cord blood stem cells (2)
human microbiome project (2)
immunology (2)
immunomodulation (2)
influenza (2)
leukapheresis (2)
leukocyte differential (2)
malaria (2)
megakaryocytes (2)
melanoma (2)
mesenchymal (2)
metastasis (2)
mitochondria (2)
next generation sequencing (2)
organogenesis (2)
pancreas (2)
primary (2)
progenitor cells (2)
proliferation (2)
prostate cancer (2)
proteasome inhibitors (2)
rheumatoid arthritis (2)
rituximab (2)
science (2)
skin (2)
spinal cord injury (2)
state (2)
stem cell gene therapy (2)
stem cell treatment (2)
stromal cells (2)
telomerase (2)
therapy (2)
thymus (2)
tolerance (2)
virus (2)
wound healing (2)
CCR5delta32 (1)
CD14+ monocytes (1)
CD15+ granulocytes (1)
CD3 (1)
CD4+ helper T cells (1)
CD8 (1)
CLEOPATRA study (1)
CMV (1)
CQAs (1)
CTC (1)
CXCL12 (1)
Central nervous system (1)
Chediak–Higashi syndrome (1)
Chronic obstructive pulmonary disease (1)
Copaxone (1)
Critical Limb Ischemia (1)
DNA damage (1)
DNASeq (1)
Drug Resistance (1)
Duchenne muscular dystrophy (1)
ELISPOT (1)
Extracellular Vesicles (1)
GDF11 (1)
GERD (1)
GMI-1070 (1)
Graft (1)
HAART (1)
HBV (1)
HIV-relevant cell populations (1)
HLA alleles (1)
HPV Vaccination (1)
Helicobacter pylori (1)
Hepatitis B Infection (1)
Human primary blood cells (1)
IL-15 (1)
IL-17 (1)
IL-2 (1)
IL-21 (1)
IL-2R (1)
INTERCEPT Blood System (1)
IgE (1)
Imetelstat (1)
Immune activation (1)
Immune suppression (1)
Infants (1)
Inflammatory bowel disease (1)
JMLL (1)
Langerhan's cells (1)
Lenti-D (1)
Lou Gehrig's disease (1)
MCB (1)
MIATA (1)
MRI (1)
MS (1)
MSC (1)
Memory T Cells (1)
Mycobacterium (1)
N-glycolylneuraminic acid (1)
NASA (1)
NMR (1)
Naive T Cells (1)
Neu5Gc (1)
New Dendritic Cell Subtypes (1)
Nicotine (1)
Nor-epinephrine (1)
Nr4a1 (1)
Otezla (1)
PD1 (1)
PTSD (1)
Parkinson's disease treatment research (1)
Point of care device (1)
Psoriasis (1)
RNA (1)
RNA vaccine (1)
Red Blood Cells (1)
Regeneration (1)
Regulatory T Cells (1)
SCIDS (1)
SCNT (1)
STINGVAX (1)
Serum (1)
Sox2 (1)
Statins (1)
Systemic lupus erythematosus (1)
T cell stem cell (1)
T regulatory cells (1)
T-cell Immune Receptors (1)
TNF-alpha (1)
Tat (1)
Th17 cells (1)
The Epstein Barr virus (1)
The John Cunningham Virus (1)
Tissue Bioengineering (1)
Type I Diabetes (1)
Tyrosine Kinase (1)
UCB (1)
ZnT8Ab (1)
aHSCT (1)
acetylcholine receptors (1)
actin (1)
acute myeloid leukemia (1)
adaptive immunity (1)
adipogenesis (1)
adipose tissue (1)
adrenoleukodystrophy (1)
advanced glycation end products (1)
affinity maturation (1)
allogeneic (1)
amyotrophic lateral sclerosis (1)
angiogenesis (1)
animal testing (1)
anti-DNA (1)
antiretroviral therapy (1)
antitumor combination therapy (1)
antitumor vaccine (1)
aspirin (1)
assay validation (1)
atherosclerosis (1)
auto-immune disease (1)
autoimmune disorder treatment (1)
babies (1)
bacterial infection (1)
beta islets (1)
biologics (1)
biomarker (1)
biomarkers (1)
biopreservation (1)
bioprinting (1)
bladder (1)
blood (1)
blood cancer (1)
blood glucose (1)
blood vessel (1)
blood-borne pathogen (1)
blood-brain barrier model (1)
blood-forming (1)
bone health indicator (1)
bone marrow mononuclear cells (1)
bone marrow transplant (1)
bone marrow-derived monocytes (1)
bone marrow-derived mononuclear stem cells (1)
bone mineral density testing (1)
bone-forming cells (1)
bowel syndrome (1)
brittle bone disease (1)
bubble boy disease (1)
buffy coat (1)
bypass (1)
cadiomyopathy (1)
calorie restriction (1)
cancer drug (1)
cancer drug assay (1)
cancer stem cells (1)
cannabinoid receptor (1)
car (1)
cardiac (1)
cardiac regeneration (1)
cardiogenesis (1)
cartilage (1)
celiac disease (1)
cell (1)
cell characterization (1)
cell collection (1)
cell culture (1)
cell division (1)
cell processing (1)
cell products (1)
cellular therapy (1)
cerebral ALD (1)
cerebral malaria (1)
cervical cancer (1)
checkpoint inhibitors (1)
chest pain (1)
chicken pox (1)
cholesterol (1)
chondroitin sulfate proteoglycan 4 (1)
chronic fatigue (1)
chronic stress (1)
circulating tumor cell (1)
circulating tumor cells (1)
coculture (1)
cold chain (1)
collagen (1)
colon cancer (1)
contamination (1)
copolymer (1)
cord blood banking (1)
cord blood transplantation (1)
coronary heart disease (1)
craniofacial (1)
craniosynostosis (1)
cytochrome P450 (1)
cytokine release (1)
cytokines (1)
decontamination (1)
dendrites (1)
dendritic cell subtypes (1)
diagnostic (1)
diet (1)
differentiation (1)
disease modeling (1)
donating blood (1)
donor cells (1)
donor lymphocyte infusion (1)
dopamine (1)
drug design (1)
drug pipeline (1)
drug toxicities (1)
drugs (1)
emerging trends (1)
engineered t cells (1)
epidermal cells (1)
epitope (1)
essential thrombocythemia (1)
exercise (1)
fasting (1)
fasting chemotherapy (1)
fat grafting (1)
fatty acid oxidation (1)
fertility (1)
fibrosis (1)
fibrotic diseases (1)
fifth pillar (1)
first in human (1)
flu (1)
fluorine-19 (1)
follicular lymphoma (1)
foot ulcers (1)
fungi (1)
fusion peptide (1)
gene silencing (1)
genetics (1)
geriartic patients (1)
glatiramer acetate (1)
gliadin (1)
glioma (1)
gluten (1)
glycated (1)
glycolysis (1)
gmp-compliant (1)
growth factors (1)
gut bacteria (1)
hair follicles (1)
heart (1)
hematological cancer (1)
hematopoiesis (1)
hemorrhagic stroke (1)
herpes virus (1)
hip arthroplasty (1)
hippocampus (1)
homing (1)
human b-1 cells (1)
human b-2 cells (1)
hypoxia (1)
iPS cells (1)
iPSC (1)
immune (1)
immune checkpoint antibody treatment (1)
immunogenic cell death (1)
immunosuppressive drugs (1)
immunosuppressive therapy (1)
in utero (1)
in-utero stem cell transplantation (1)
infections (1)
inflammation prevention (1)
inhibitor of differentiation (1)
innate immunity (1)
innovation (1)
interleukin (1)
interleukins (1)
intracellular pathogens (1)
intracerebral hemorrhage (1)
ipilimumab (1)
ischemia (1)
isoenzymes (1)
knee arthroplasty (1)
legionella (1)
leishmania-macrophages (1)
leukapharesis procedures (1)
leukocytes (1)
liver cirrhosis (1)
liver disease (1)
liver inflammation (1)
lower limb ischemia (1)
lung cancer (1)
macropinocytosis (1)
magnetic resonance imaging (1)
male infertility (1)
manufacturing (1)
mass cytometry (1)
mass-tag cellular barcoding (1)
melanoma immunotherapy (1)
mesothelioma (1)
metanephroi (1)
metastatic bladder cancer (1)
metformin (1)
microbial (1)
microgravity (1)
microvesicles (1)
migration (1)
minimal residual disease (1)
mobilized peripheral blood (1)
monoclonal antibody (1)
mulitiple sclerosis (1)
multiple myeloma (1)
multiplex gene expression analysis (1)
myasthenia gravis (1)
myelin basic protein (1)
myelin sheath (1)
myelofibrosis (1)
myeloid (1)
myeloid cells (1)
myeloid-derived suppressor cells (1)
myeloproliferative neoplasms (1)
myocardial infarction (1)
myofibroblasts (1)
neoepitope (1)
nerve tissue (1)
nervous system (1)
neurodegenerative diseases (1)
neuroinflammation (1)
neuronal development (1)
neurons (1)
neurotrophic factor (1)
non-hodgkin lymphoma (1)
nucleoside analog (1)
obesity (1)
obinutuzumab (1)
omega-3 fatty acids (1)
oncolytic virus (1)
organ donors (1)
organ transplantation (1)
organ transplants (1)
osteoarthritis (1)
osteocytes (1)
osteogenesis imperfecta (1)
osteoprogenitors (1)
oxidative phosphorylation (1)
p11 (1)
paracine factors (1)
paralysis (1)
partnering (1)
patrol (1)
pax7 (1)
pegylated interferon (1)
pembrolizumab (1)
peptides (1)
pericytes (1)
personalized medicine (1)
pertuzumab (1)
phosphorylation (1)
physiological stress (1)
platelet recovery (1)
platelet-rich plasma (1)
plerixafor (1)
pluripotency (1)
pluripotent (1)
pneumonia (1)
pnv (1)
point of care test (1)
polarized dendritic cells (1)
population genetics (1)
preclinical (1)
prediction (1)
pregnancy (1)
prenatal (1)
prescription (1)
primary cilia (1)
primary immune deficiency treatment consortium (1)
prostate cancer treatment (1)
protein synthesis (1)
proteins (1)
purified peripheral blood mononuclear cells (1)
radiation-responsive genes (1)
rectal cancer (1)
red meat (1)
respiration (1)
restorative surgery (1)
scientific research (1)
self-reactive (1)
shRNA (1)
shingles (1)
shingles vaccine (1)
signal transduction (1)
skin associated lymphoid tissue (1)
skin cancer (1)
skin immunization (1)
social anxiety (1)
solid tumors (1)
somatic cells (1)
somatic hypermutation (1)
sortases (1)
spermatozoa (1)
stemness (1)
stomach (1)
streptozotocin (1)
stroke (1)
surveillance (1)
telomere (1)
tetraspanin (1)
tissue regeneration (1)
toll like receptors (1)
transplant (1)
transwell (1)
trastuzumab (1)
treatment (1)
triple-negative breast cancer (1)
trophic factors (1)
tuberculosis (1)
tumor microenvironment (1)
vaccination (1)
vaccine adjvant (1)
varicella zoster virus (1)
vascular disease (1)
vascular repair (1)
viability (1)
vitamin D (1)
whole exome sequencing (1)
world donate blood day (1)

see all

Blog | HemaCare

Skin Cells to Stem Cells: The New Face of Cellular Therapy

Subscribe Here!

Posts by Topic

Recent Posts